HOME >> BIOLOGY >> NEWS
Study Suggests Vaccine Increases Survival In Ovarian And Breast Cancer Patients Following High-Dose Chemotherapy And Autologous Stem Cell Transplant

A new study suggests that the administration of an experimental cancer vaccine following autologous stem cell transplant can increase survival and decrease relapse in ovarian and breast cancer patients when compared to the stem cell transplant procedure alone. The data was presented today at the 35th annual meeting of the American Society of Clinical Oncology (ASCO) in Atlanta, May 15-18, 1999.

The research team at the Fred Hutchinson Cancer Research Center, led by Leona Holmberg, M.D., Ph.D., and Brenda Sandmaier, M.D., treated 40 cancer patients (11 high-risk stage II/III breast, 22 stage IV breast and 7 stage III/IV ovarian) with high-dose chemotherapy followed by autologous/syngeneic stem cell transplantation. Twenty-six of the 40 patients also received five doses of THERATOPEO vaccine (STn-KLH), a therapeutic vaccine being developed by Biomira, Inc. of Alberta, Canada (NASDAQ: BIOM) (TSE, ME: BRA) that induces the body's immune system to mount a response against cancerous cells.

All patients were treated between Sept. 1, 1995 and Nov. 18, 1997. To gain preliminary evidence of the potential efficacy of the THERATOPE vaccine, the outcome of vaccinated patients was retrospectively compared to the outcome of patients not vaccinated.

Investigators found that the chance of death was more than 2 times greater among patients in the control group compared to patients vaccinated with THERATOPEO vaccine. The chance of relapse was approximately 1.7 times greater for patients in the control group compared to those vaccinated. In addition, those vaccinated patients with the highest amount of specific killing activity against STn-bearing cancer cells appeared to remain the longest in remission.

According to Dr. Holmberg, M.D., Ph.D., THERATOPEO vaccine was well tolerated after autologous stem cell transplant and in preliminary data may have improved outcomes. These results need to be considered within the debate over hematopoietic stem cell transpl
'"/>

Contact: Susan Edmonds
sedmonds@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
15-May-1999


Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2020)... ... 2020 , ... Nominations are now being accepted for the 2020 Women ... (SIA) and SecureIDNews and co-presented with sponsors IDEMIA , ... of this year’s Women in Biometrics Awards will be honored at the 2020 SIA ...
(Date:2/28/2020)... ... 2020 , ... Meridian Clinical Research , a leading investigative research network, ... for Best Clinical Trial Site. Meridian is also the largest member of Platinum ... These nominations were the result of two voting rounds, and winners will be announced ...
(Date:2/28/2020)... ... February 27, 2020 , ... An ... innovative treatment solutions for maladies, such as Inflammatory Bowel Disease (IBD), specifically Crohn’s ... segment will focus on a novel platform developed by Deka Biosciences, Inc. (Deka ...
Breaking Biology News(10 mins):
(Date:3/12/2020)... ... March 12, 2020 , ... ... microscopy (AFM) technology, increases the business investment in Europe by inaugurating a new ... Grand Opening Ceremony of the new Nanoscience Center Europe took place Tuesday, February ...
(Date:3/4/2020)... ... March 04, 2020 , ... ... services, today announced the launch of its FleXpress™ high-throughput recombinant antibody production ... of antibodies at 80 ml scale. All production occurs in Absolute Antibody’s ...
(Date:3/2/2020)... ... March 02, 2020 , ... McBee, Moore and Vanik ... list in the field of Biotechnology and Organics. , According to statistics compiled by ... of 259 patents issued in technology center 1600 during 2019. Technology center 1600 at ...
(Date:2/21/2020)... (PRWEB) , ... February 20, ... ... an exquisite capability to perform complex, efficient and elegant chemistry. Humans have ... algorithms to our own goals. , Through rapidly evolving technologies and strategies ...
Breaking Biology Technology:
Cached News: